Back to Authors

Friedman, Kevin

Mayo Clinic

From the Massachusetts General Hospital Cancer Center (N.R., M.V.M.), Beth Israel Deaconess Medical Center (J.R.), and Dana-Farber Cancer Institute and Veterans Affairs Boston Healthcare System (N.M.), Boston, and Bluebird Bio, Cambridge (A.T., L.-P.L., R.

Citations 1

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

New England Journal of Medicine | May 1, 2019 | Volume: 380 | Issue: 18 | Pages: 1726-1737

10.1056/nejmoa1817226 | PMID 31042825